Compare FARM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FARM | HBIO |
|---|---|---|
| Founded | 1912 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3M | 24.9M |
| IPO Year | 1994 | 2000 |
| Metric | FARM | HBIO |
|---|---|---|
| Price | $1.28 | $5.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $2.75 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 191.2K | 28.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $342,281,000.00 | $116,176,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | $0.57 | $8.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.35 | N/A |
| 52 Week Low | $1.21 | $0.28 |
| 52 Week High | $2.06 | $7.50 |
| Indicator | FARM | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 47.35 |
| Support Level | $1.21 | $4.42 |
| Resistance Level | $1.58 | $5.79 |
| Average True Range (ATR) | 0.01 | 0.46 |
| MACD | 0.01 | -0.18 |
| Stochastic Oscillator | 75.00 | 24.52 |
Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.